Bon Natural Life Limited Class A Ordinary Shares (BON)

FairStock Score: 45/100 — MIXED

Key Financials

AI Analysis

AI-generated, general educational analysis — not personal investment advice.

Looking at Bon Natural Life, I see a tiny specialty chemicals business with a $10.5 million market value, 96 employees, and sales of natural herb extracts for fragrances, personal care, and health supplements across China, Europe, North America, and the Middle East. The idea may have niche appeal, but the figures do not yet show a durable franchise. At the 2026-10-13 close of $1.12, FairStock's calculations put the price at 0.12 times book, which looks statistically cheap. But the earnings picture is negative: the P/E is -1.56, ROE is -4.00%, and ROCE is -1.38%. A Piotroski F-Score of 0/9 and an Altman Z-Score of 0.78 suggest weak financial health and real distress risk, not a hidden bargain. Debt is modest with D/E at 0.21, and beta is -0.24, but low leverage alone does not make a business profitable. The lack of a Lynch category, because there are only 0 years of filed results versus the 3 needed, tells me there is no track record to underwrite. Growth data for revenue and profit is not available, so I cannot verify improving trends. The FairStock Score is 45/100. Graham would ask whether assets are worth more than the price; Buffett would ask whether the business can earn a return. Here, the asset discount is obvious, but the earning power is not. Until I see filed evidence of positive earnings and returns, this looks more like a speculative low-priced microcap than a safe value investment.

In plain English: Bon Natural Life Limited makes natural ingredient products from herbs for fragrances, personal care, and health supplements, mainly in China but also other regions. The business looks weak right now: it is losing money and has very low financial-health scores, with no multi-year record in the data. The share price looks very cheap compared with the company's assets on the books, but that cheapness comes with high risk because the company is not profitable.

The full AI analysis, bull and bear case and key monitorables are in FairStock Pro.

Data as of 2026-10-13 close · note generated 2026-10-15 · model deepseek-flash

Fundamentals from company filings and market-data providers; prices are end-of-day, not real-time. AI-generated analysis is general and educational — not personal investment advice. Scoring methodology · Score test · Disclaimer